The French pharma industry experienced a 39% drop in new job postings in Q3 2023 compared with the previous quarter, with the highest share accounted for by AstraZeneca with 189 job postings according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for an 8% share of the French pharma industry new job postings in Q3 2023, down by 40% over the prior quarter.
Management Occupations drive pharma industry hiring activity
Of the industry's total hiring activity, the highest number of new job postings were for Management Occupations, which accounted for 8% of the total new job postings in Q3 2023 and were down by 64% year-on-year. Second highest were Healthcare Practitioners and Technical Occupations, which accounted for 4% and drop by 75% year-on-year, and third highest were Business and Financial Operations Occupations, which were 60% of the new job postings and 84% lower year-on-year.
Top five companies in pharma industry accounted for 40% of hiring activity
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe highest number of jobs were posted by AstraZeneca with 189, followed by Sanofi with 93, while the highest increase was at Novo Nordisk at 65%.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.